KBTBD11通过向ENO1介导的糖解来抑制肝细胞癌
Yixuan Liu1, Yiran Chen1, Lirui Tang1
1Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Journal of translational medicine
|October 15, 2025
概括
KBTBD11通过降解ENO1,这是有氧糖解中的关键参与者,从而抑制肝癌 (HCC). 这一发现揭示了KBTBD11作为一种瘤抑制剂和HCC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢过程中的代谢.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因之一.
- 增强的有氧糖解是一种已知的HCC的标志,但其调节尚未完全理解.
研究的目的:
- 为了在HCC.中识别新的代谢调节剂.
- 阐明 KBTBD11 在 HCC 进展和糖解中的作用.
主要方法:
- 基因组范围的CRISPR-Cas9屏幕在一个正型HCC模型中.
- 在体外功能测试 (细胞外流量,ATP/乳酸量化,ROS,亡).
- 共同免疫沉,无处不在的测试,PLA和免疫光以研究蛋白质相互作用.
主要成果:
- KBTBD11在HCC下调,并与更好的预后有关.
- KBTBD11的过度表达抑制了葡萄糖分解,减少了ATP/乳酸盐,增加了ROS,并促进了亡.
- KBTBD11与ENO1相互作用,促进其依赖于乌比基的蛋白质体降解.
结论:
- KBTBD11 作为 HCC.中 ENO1 驱动的糖解的负调节剂.
- KBTBD11将乌比奎信号与肝癌中的代谢控制和瘤抑制联系起来.
- KBTBD11代表了HCC的潜在治疗标.
关键词:
在 ENO1 中, ENO1 是 ENO1 的代码.葡萄糖溶解是什么? 葡萄糖溶解肝细胞癌是肝细胞癌.在 KBTBD11 里.代谢重编程是一种代谢重编程.在Ubiquitination中使用.更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
872
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
